Veracyte (VCYT) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $44.39, +2.02% vs the prior close of $43.51.
- Volume 1.23M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VCYT rises 2.0% to $44.39. Closed at $44.39, +2.02% vs the prior close of $43.51. Day range $42.70–$45.58, opened at $43.36.
VCYT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — VCYT rises 2.0% to $44.39
- Closed at $44.39, +2.02% vs the prior close of $43.51. Day range $42.70–$45.58, opened at $43.36.
- Volume was 1.23M shares, 0.9x its 50-day average of 1.32M.
- Price is +1.8% vs its 50-day average ($43.59) and +4.2% vs its 200-day average ($42.58).
- 52-week range $29.45–$60.91; today's close sits at 47% of that range, 27.1% below the 52-week high.
Oct 14, 2026 — VCYT rises 0.9% to $43.51
- Closed at $43.51, +0.93% vs the prior close of $43.11. Day range $42.20–$43.99, opened at $42.37.
- Volume was 935.30K shares, 0.7x its 50-day average of 1.34M.
- Price is -0.3% vs its 50-day average ($43.63) and +2.2% vs its 200-day average ($42.58).
- 52-week range $29.45–$60.91; today's close sits at 45% of that range, 28.6% below the 52-week high.
Oct 13, 2026 — VCYT dips 2.1% to $43.11
- Closed at $43.11, -2.07% vs the prior close of $44.02. Day range $43.03–$44.29, opened at $43.67.
- Volume was 760.40K shares, 0.6x its 50-day average of 1.36M — lighter than usual.
- Price is -1.3% vs its 50-day average ($43.68) and +1.3% vs its 200-day average ($42.57).
- 52-week range $29.45–$60.91; today's close sits at 43% of that range, 29.2% below the 52-week high.
Oct 12, 2026 — VCYT dips 2.7% to $44.02
- Closed at $44.02, -2.68% vs the prior close of $45.23. Day range $43.29–$45.22, opened at $45.18.
- Volume was 1.15M shares, 0.8x its 50-day average of 1.46M.
- Price is +0.7% vs its 50-day average ($43.72) and +3.4% vs its 200-day average ($42.57).
- 52-week range $29.45–$60.91; today's close sits at 46% of that range, 27.7% below the 52-week high.
Oct 9, 2026 — VCYT jumps 3.7% to $45.23
- Closed at $45.23, +3.74% vs the prior close of $43.60. Day range $43.50–$46.17, opened at $43.71.
- Volume was 966.50K shares, 0.7x its 50-day average of 1.47M.
- Price is +3.3% vs its 50-day average ($43.76) and +6.3% vs its 200-day average ($42.56).
- 52-week range $29.45–$60.91; today's close sits at 50% of that range, 25.7% below the 52-week high.
Oct 8, 2026 — VCYT rises 1.0% to $43.60
- Closed at $43.60, +1.02% vs the prior close of $43.16. Day range $41.22–$43.67, opened at $42.50.
- Volume was 1.22M shares, 0.8x its 50-day average of 1.46M.
- Price is -1.0% vs its 50-day average ($44.06) and +2.5% vs its 200-day average ($42.55).
- 52-week range $29.45–$60.91; today's close sits at 45% of that range, 28.4% below the 52-week high.
Oct 7, 2026 — VCYT slides 3.3% to $43.16
- Closed at $43.16, -3.34% vs the prior close of $44.65. Day range $42.34–$44.21, opened at $44.04.
- Volume was 1.21M shares, 0.8x its 50-day average of 1.45M.
- Price is -2.6% vs its 50-day average ($44.30) and +1.4% vs its 200-day average ($42.55).
- 52-week range $29.45–$60.91; today's close sits at 44% of that range, 29.1% below the 52-week high.
Oct 6, 2026 — VCYT slides 6.3% to $44.65
- Closed at $44.65, -6.34% vs the prior close of $47.67. Day range $44.09–$48.84, opened at $48.00.
- Volume was 1.73M shares, 1.2x its 50-day average of 1.43M.
- Price is +0.2% vs its 50-day average ($44.55) and +4.9% vs its 200-day average ($42.54).
- 52-week range $29.45–$60.91; today's close sits at 48% of that range, 26.7% below the 52-week high.
Oct 5, 2026 — VCYT jumps 4.1% to $47.67
- Closed at $47.67, +4.06% vs the prior close of $45.81. Day range $45.00–$47.78, opened at $45.75.
- Volume was 1.29M shares, 0.9x its 50-day average of 1.42M.
- Price is +6.5% vs its 50-day average ($44.77) and +12.1% vs its 200-day average ($42.53).
- 52-week range $29.45–$60.91; today's close sits at 58% of that range, 21.7% below the 52-week high.
Oct 2, 2026 — VCYT jumps 3.7% to $45.81
- Closed at $45.81, +3.67% vs the prior close of $44.19. Day range $44.41–$46.09, opened at $44.94.
- Volume was 1.04M shares, 0.7x its 50-day average of 1.41M.
- Price is +1.9% vs its 50-day average ($44.95) and +7.8% vs its 200-day average ($42.51).
- 52-week range $29.45–$60.91; today's close sits at 52% of that range, 24.8% below the 52-week high.
VCYT latest news & SEC filings
Every SEC filing by or about VCYT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 24, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 22, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Leite John sold 4,015 shares at $40.00 (≈$160.60K) on Sep 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 21, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 16, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Holstein Jens sold 5,000 shares at $40.95 (≈$204.75K) on Sep 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 4, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 31, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $150.32M (prior year $130.16M) (+15.5% vs Jun 30, 2025)
- Net income: $25.49M (prior year -$980.00K) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.31 (prior year -$0.01) (swung to profit vs Jun 30, 2025)
Jul 30, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade VCYT
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 25, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.26% (largest 10.8%). That is a volatile stock.
- Liquidity: about 1.46M shares (≈$64.77M) trade per day on average.
- 52-week position: $44.39 vs a range of $29.45–$60.91 (47% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: John Leite sold 4,015 shares on Sep 21, 2026.
- Latest filings: 8-K Sep 14, 2026; 10-Q Jul 31, 2026; 8-K Jul 30, 2026.
- Share count: 80.39M shares outstanding (Jul 27, 2026), +2.2% vs a year earlier.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
VCYT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 43.36 | 45.58 | 42.70 | 44.39 | 1.23M |
| Oct 14, 2026 | 42.37 | 43.99 | 42.20 | 43.51 | 935.30K |
| Oct 13, 2026 | 43.67 | 44.29 | 43.03 | 43.11 | 760.40K |
| Oct 12, 2026 | 45.18 | 45.22 | 43.29 | 44.02 | 1.15M |
| Oct 9, 2026 | 43.71 | 46.17 | 43.50 | 45.23 | 966.50K |
| Oct 8, 2026 | 42.50 | 43.67 | 41.22 | 43.60 | 1.22M |
| Oct 7, 2026 | 44.04 | 44.21 | 42.34 | 43.16 | 1.21M |
| Oct 6, 2026 | 48.00 | 48.84 | 44.09 | 44.65 | 1.73M |
| Oct 5, 2026 | 45.75 | 47.78 | 45.00 | 47.67 | 1.29M |
| Oct 2, 2026 | 44.94 | 46.09 | 44.41 | 45.81 | 1.04M |
| Oct 1, 2026 | 45.66 | 47.14 | 44.18 | 44.19 | 1.43M |
| Sep 30, 2026 | 45.93 | 46.78 | 45.60 | 46.04 | 1.18M |
| Sep 29, 2026 | 46.00 | 47.52 | 45.21 | 46.08 | 1.59M |
| Sep 28, 2026 | 45.04 | 47.52 | 44.47 | 45.23 | 1.70M |
| Sep 25, 2026 | 49.00 | 49.00 | 45.36 | 45.43 | 1.73M |
| Sep 24, 2026 | 43.66 | 48.95 | 43.51 | 48.54 | 2.88M |
| Sep 23, 2026 | 42.95 | 43.86 | 42.25 | 43.82 | 1.53M |
| Sep 22, 2026 | 41.76 | 43.74 | 41.31 | 43.36 | 1.47M |
| Sep 21, 2026 | 40.00 | 41.98 | 39.40 | 41.52 | 1.47M |
| Sep 18, 2026 | 40.41 | 41.05 | 39.55 | 39.79 | 2.67M |
About Veracyte
Veracyte (VCYT) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1384101.
VCYT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Eliav Barr | Director | Jun 15, 2026 |
| Muna Bhanji | Director | Sep 3, 2026 |
| Karin Eastham | Director | Jun 22, 2026 |
| Robert S Epstein | Director | Jun 15, 2026 |
| Jens Holstein | Director | Sep 16, 2026 |
| Evan/ Fa Jones | Director | Jun 15, 2026 |
| Thomas F. Miller | Director | Jun 15, 2026 |
| David Brent Shafer | Director | Jun 15, 2026 |
| Marc Stapley | Chief Executive Officer | Sep 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Rebecca Chambers | Chief Financial Officer | Sep 4, 2026 |
| Phillip G. Febbo | Chief Scientific & Med Officer | Sep 4, 2026 |
| Kevin Richard Haas | Chief Dev and Tech Officer | Apr 14, 2026 |
| John Leite | Global Chief Commercial Off | Sep 22, 2026 |
| Annie Mcguire | EVP, General Counsel | Sep 4, 2026 |
| Marc Stapley | Chief Executive Officer | Sep 4, 2026 |
| Jonathan Wygant | VP, Chief Accounting Officer | Sep 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 21, 2026 | John Leite | Sale | 4,015 | $40.00 |
| Sep 14, 2026 | Jens Holstein | Sale | 5,000 | $40.95 |
| Sep 4, 2026 | Rebecca Chambers | Sale | 1,175 | $43.71 |
| Sep 4, 2026 | Rebecca Chambers | Sale | 2,477 | $42.81 |
| Sep 4, 2026 | Annie Mcguire | Sale | 1,100 | $43.67 |
| Sep 4, 2026 | Annie Mcguire | Sale | 2,154 | $42.79 |
| Sep 4, 2026 | Phillip G. Febbo | Sale | 10,405 | $42.89 |
| Sep 4, 2026 | Phillip G. Febbo | Sale | 2,705 | $43.66 |
| Sep 1, 2026 | Muna Bhanji | Sale | 1,864 | $42.97 |
| Jun 18, 2026 | Karin Eastham | Sale | 3,200 | $52.78 |
| Jun 18, 2026 | Karin Eastham | Sale | 529 | $53.55 |
| Jun 4, 2026 | Annie Mcguire | Sale | 1,776 | $50.12 |
| Jun 4, 2026 | Annie Mcguire | Sale | 1,400 | $49.31 |
| Jun 4, 2026 | Marc Stapley | Sale | 138,051 | $50.12 |
| Jun 4, 2026 | Rebecca Chambers | Sale | 1,600 | $49.28 |
VCYT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $517.14M | $66.35M | 0.82 | $136.31M |
| Dec 31, 2024 | $445.76M | $24.14M | 0.31 | $75.10M |
| Dec 31, 2023 | $361.05M | $-74.40M | -1.02 | $44.22M |
| Dec 31, 2022 | $296.54M | $-36.56M | -0.51 | $7.54M |
| Dec 31, 2021 | $219.51M | $-75.56M | -1.11 | $-31.62M |
Latest balance sheet: total assets $1.49B, total liabilities $97.96M, cash $299.52M (as of Jun 30, 2026).
VCYT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $59.78 |
| May 5, 2026 | 8-K Item 2.02 (results) | $32.97 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $35.72 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $43.45 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $36.12 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $23.97 |
| May 7, 2025 | 8-K Item 2.02 (results) | $30.84 |
| Feb 24, 2025 | 8-K Item 2.02 (results) | $39.36 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $36.59 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 22, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Quest Diagnostics (DGX)Guardant Health (GH)Labcorp (LH)Celcuity (CELC)Caris Life Sciences (CAI)Grail (GRAL)CareDx (CDNA)Fortrea (FTRE)BillionToOne (BLLN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on VCYT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.